117 related articles for article (PubMed ID: 28034736)
21. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
Nair A; Vyas H; Shah J; Kumar A
Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
[TBL] [Abstract][Full Text] [Related]
22. Effect of modulated alternating and direct current iontophoresis on transdermal delivery of lidocaine hydrochloride.
Bhatia G; Banga AK
Biomed Res Int; 2014; 2014():537941. PubMed ID: 24959580
[TBL] [Abstract][Full Text] [Related]
23. Transdermal iontophoretic delivery of vapreotide acetate across porcine skin in vitro.
Schuetz YB; Naik A; Guy RH; Vuaridel E; Kalia YN
Pharm Res; 2005 Aug; 22(8):1305-12. PubMed ID: 16078140
[TBL] [Abstract][Full Text] [Related]
24. Controlled intra- and transdermal protein delivery using a minimally invasive Erbium:YAG fractional laser ablation technology.
Bachhav YG; Heinrich A; Kalia YN
Eur J Pharm Biopharm; 2013 Jun; 84(2):355-64. PubMed ID: 23207321
[TBL] [Abstract][Full Text] [Related]
25. The influence of positive or negative charges in the passive and iontophoretic skin penetration of porphyrins used in photodynamic therapy.
Gelfuso GM; Gratieri T; Souza JG; Thomazine JA; Lopez RF
Eur J Pharm Biopharm; 2011 Feb; 77(2):249-56. PubMed ID: 21118720
[TBL] [Abstract][Full Text] [Related]
26. In-vitro and in-vivo transdermal iontophoretic delivery of tramadol, a centrally acting analgesic.
Takasuga S; Yamamoto R; Mafune S; Sutoh C; Kominami K; Yoshida Y; Ito M; Kinoshita M
J Pharm Pharmacol; 2011 Nov; 63(11):1437-45. PubMed ID: 21988424
[TBL] [Abstract][Full Text] [Related]
27. Passive and iontophoretic transdermal penetration of chlorpromazine.
Alvarez-Figueroa MJ; González-Aramundiz JV
Pharm Dev Technol; 2008; 13(4):271-5. PubMed ID: 18649217
[TBL] [Abstract][Full Text] [Related]
28. Short-term iontophoretic and post-iontophoretic transport of model penetrants across excised human epidermis.
Akomeah FK; Martin GP; Brown MB
Int J Pharm; 2009 Feb; 367(1-2):162-8. PubMed ID: 18950696
[TBL] [Abstract][Full Text] [Related]
29. Contributions of electromigration and electroosmosis to peptide iontophoresis across intact and impaired skin.
Abla N; Naik A; Guy RH; Kalia YN
J Control Release; 2005 Nov; 108(2-3):319-30. PubMed ID: 16169627
[TBL] [Abstract][Full Text] [Related]
30. Transdermal iontophoretic delivery of triptorelin in vitro.
Schuetz YB; Naik A; Guy RH; Vuaridel E; Kalia YN
J Pharm Sci; 2005 Oct; 94(10):2175-82. PubMed ID: 16136544
[TBL] [Abstract][Full Text] [Related]
31. Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery.
Abla N; Naik A; Guy RH; Kalia YN
Pharm Res; 2006 Aug; 23(8):1842-9. PubMed ID: 16850271
[TBL] [Abstract][Full Text] [Related]
32. Transdermal iontophoretic delivery of a liquid lipophilic drug by complexation with an anionic cyclodextrin.
Juluri A; Narasimha Murthy S
J Control Release; 2014 Sep; 189():11-8. PubMed ID: 24950431
[TBL] [Abstract][Full Text] [Related]
33. Iontophoretic transdermal delivery of sumatriptan: effect of current density and ionic strength.
Femenía-Font A; Balaguer-Fernández C; Merino V; López-Castellano A
J Pharm Sci; 2005 Oct; 94(10):2183-6. PubMed ID: 16136550
[TBL] [Abstract][Full Text] [Related]
34. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist.
Yamamoto R; Takasuga S; Yoshida Y; Mafune S; Kominami K; Sutoh C; Kato Y; Yamauchi M; Ito M; Kanamura K; Kinoshita M
Int J Pharm; 2012 Jan; 422(1-2):132-8. PubMed ID: 22108639
[TBL] [Abstract][Full Text] [Related]
36. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
[TBL] [Abstract][Full Text] [Related]
37. Transdermal and intradermal iontophoretic delivery of dexamethasone sodium phosphate: quantification of the drug localized in skin.
Paturi J; Kim HD; Chakraborty B; Friden PM; Banga AK
J Drug Target; 2010 Feb; 18(2):134-40. PubMed ID: 19772394
[TBL] [Abstract][Full Text] [Related]
38. Controlled delivery of ropinirole hydrochloride through skin using modulated iontophoresis and microneedles.
Singh ND; Banga AK
J Drug Target; 2013 May; 21(4):354-66. PubMed ID: 23311703
[TBL] [Abstract][Full Text] [Related]
39. Enhanced topical paromomycin delivery for cutaneous leishmaniasis treatment: Passive and iontophoretic approaches.
de Sá FAP; Andrade JFM; Miranda TC; Cunha-Filho M; Gelfuso GM; Lapteva M; Kalia YN; Gratieri T
Int J Pharm; 2023 Dec; 648():123617. PubMed ID: 37977289
[TBL] [Abstract][Full Text] [Related]
40. In vitro transdermal iontophoretic delivery of penbutolol sulfate.
Ita KB; Banga AK
Drug Deliv; 2009 Jan; 16(1):11-4. PubMed ID: 19555303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
